mutations in mecI or the mec promoter region. 10 Regulation of methicillin resistance in MRCNS may, therefore, differ from that in MRSA.
The aim of this investigation was to study the distribution of mecA, mecR1 and mecI in a genetically diverse collection of staphylococcal species. The presence of these genes was correlated with the methicillin MIC for each isolate. Furthermore, the integrity of mecI and the mec promoter region in isolates carrying mecI was examined by nucleotide sequence analysis. This was performed to locate mutations present in these regions that might explain expression of resistance to methicillin in the presence of the repressor gene.
Materials and methods

Bacterial isolates
The bacteria examined were a collection of 144 isolates of staphylococci. They comprised 42 S. aureus and 102 CNS, including 67 S. epidermidis, 12 Staphylococcus haemolyticus, 12 Staphylococcus simulans, five Staphylococcus warneri, two Staphylococcus xylosus, two Staphylococcus capitis and two Staphylococcus hominis. The MIC of methicillin for each isolate by agar incorporation and Etest was available from previous investigations of methicillinsusceptibility testing techniques. 13, 14 Isolates were classified as resistant if the MIC was 8 mg/L.
Preparation of DNA
Staphylococcal cells from a single colony of overnight growth were washed and suspended in 400 L of lysis solution (50 mM Tris, pH 8, 5 mM EDTA, pH 8, 50 mM NaCl). Lysostaphin (Ambi UK, Trowbridge, UK) was added to a final concentration of 20 mg/L. The suspension was incubated at 37°C, with gentle shaking, for 60 min. The mixture was incubated for a further 2 h at 50°C after the addition of 80 L of proteinase solution (50 mM Tris, 0.4 M EDTA, pH 8, 0.5% sodium dodecyl sulphate containing 0.5 mg proteinase K (Boehringer Mannheim, Lewes, UK)). DNA was extracted with 200 L each of phenol and chloroform and the mixture was centrifuged at 13,000g for 5 min. The top layer was removed, mixed with an equal volume of ice-cold ethanol and then centrifuged as before. The DNA pellet was resuspended in 25 L TE (10 mM Tris, 1 mM EDTA, pH 8) buffer and stored at -20°C until needed.
Primers
The mecA gene was amplified with primers MR1 and MR2 (Table I) , previously described by Tokue et al. 15 MR3, located within the region amplified by MR1 and MR2, was designed as a probe by Tokue et al. 15 In this study it was used as a third primer with primer MR2 for confirmatory semi-nested PCR using methods described by Falla et al. 16 Primers were designed for mecR1 (TMW15 and TMW16), mecI (TMW17 and TMW18) and the mec promoter region (TMW30 and TMW31) ( Table I) from published gene sequences 6, 17, 18 with Oligo software (National Biosciences, Plymouth, MN, USA). Primers used for amplification of mecI prior to sequencing (TMW19 and TMW20) (Table I) The primary product underwent a further cycle of seminested PCR amplification to confirm its identity. A 2 L sample of the original reaction mixture was used as DNA template in a further reaction mixture constituted as previously, but with primers MR2 and MR3. Amplification and electrophoresis were performed as before to detect a 785 bp product.
Primers TMW15 and TMW16 were used to detect a 414 bp mecR1 product by the same method as above. To amplify mecI with primers TMW17 and TMW18, the annealing temperature was reduced to 50°C and the 265 bp product was separated on a 2% agarose gel, but otherwise conditions were the same. The specificity of the primers was validated by sequencing the products obtained from isolate TME14 by the method described below.
Sequencing of the mecI gene and the mec promoter region
The nucleotide sequence of the mecI gene was determined for 10 mecI-positive S. aureus and 15 CNS isolates chosen as a representative sample. DNA template was diluted 1 in 100 and 4 L was used in a 40 L reaction mixture containing 1 unit of Taq polymerase, 200 M of each dNTP, 1.5 mM MgCl 2 , 75 mM Tris-HCl pH 9.0, 20 mM (NH 4 ) 2 SO 4 , 0.01% Tween 20 and 250 nM each of primers TMW19 and TMW20. Thirty cycles of amplification were performed, each consisting of 60 s at 95°C, 60 s at 50°C and 2 min at 72°C. The 480 bp product included the entire mecI gene.
The primary product was purified using a C-100 Centricon column (Amicon, Gloucester, UK) and then reamplified with each primer individually in separate reaction mixtures. A total volume of 20 L was used including 4 L of Amplitaq DNA polymerase terminator mix (Applied Biosystems, Warrington, UK), 2 L of primer, and 30-90 ng of DNA template. Twenty-four cycles consisted of 30 s at 96°C, 15 s at 50°C and 4 min at 60°C. The product was mixed with 50 L of 95% ethanol and 2 L of 3 M sodium acetate and placed on ice for 10 min. It was then centrifuged at 13,000g for 30 min and the ethanol removed before allowing the DNA pellet to dry. The nucleotide sequence was determined on an Applied Biosystems model 373A automated DNA sequencer.
For each isolate, the sequences obtained using each primer were compared using ABI Prism DNA Sequencing Analysis Software (Applied Biosystems) and a consensus sequence was computed. The consensus sequence of mecI for each test isolate was then compared with the published sequence from pre-MRSA strain N315. 6 Primers TMW30 and TMW31 were used as above to amplify and sequence the mec promoter region and the consensus sequence from each test isolate was compared with the published sequence from pre-MRSA strain N315. 6 
Pulsed-field gel electrophoresis
Pulsed-field gel electrophoresis (PFGE) was performed on all mecA-positive staphylococci to determine their genetic relatedness. Five colonies of an overnight culture were harvested into 1 mL TEN buffer (0.1 M Tris-HCl, 0.15 M NaCl, 0.1 M EDTA pH 8). Cells were washed twice and resuspended in 0.3 mL EC buffer (6 mM Tris-HCl, 1 M NaCl, 0.1 M EDTA, pH 8, 0.5% 20 cetyl ether, 0.2% deoxycholate, 0.5% n-lauroylsarcosine). Fifty microlitres of this cell suspension was mixed with 25 L of lysostaphin (200 mg/L) and then 200 L of 1% InCert agarose (FMC BioProducts, Rockland, ME, USA) was added. The mixture was allowed to solidify at 4°C for 10 min in a gel plug mould. The solid plug was incubated overnight in 2 mL of EC buffer at 37°C. This was replaced by 2 mL of PB buffer (0.5 M EDTA, pH 8, 1% sarkosyl, proteinase K 1 mg/mL) for a further overnight incubation and then the gel plug was washed six times in 5 mL of TE buffer for 30 min each time to remove proteinase K. Gel plugs were stored in 1 mL of fresh TE buffer at 4°C until needed.
DNA was digested with the restriction endonuclease SmaI Electrophoresis was performed with the CHEF-DR III electrophoresis cell (Bio-Rad, Hemel Hempstead, UK) on a 1% agarose gel with the following electrophoresis parameters: 6 V/cm for 24 h at 14°C; initial pulse time, 10 s; final pulse time, 25 s. A control strain, S. aureus NCTC 8325, with fragments of known sizes, 19 was run on each gel to allow comparison. Gels were stained with ethidium bromide 0.5 mg/L and visualized under ultraviolet light.
The resulting band patterns were compared visually. Isolates with indistinguishable patterns were grouped together and those with patterns distinguishable from all other isolates were designated as 'unique'.
Results
Detection of mecA
The primary mecA gene product of 1339 bp was found in 21 of the 42 isolates of S. aureus tested and in 44 of the 102 CNS examined. All these positive isolates produced the predicted 785 bp product on confirmatory semi-nested PCR.
Methicillin MIC
All mecA-negative staphylococci had MICs 8 mg/L as determined by methicillin Etest.
14 All mecA-positive staphylococci had MICs 8 mg/L by at least one of the susceptibility tests performed; none were classified as pre-MRSA or pre-MRCNS. 13, 14 The MICs determined by methicillin Etest on Columbia 5% NaCl agar are shown in Tables II and III .
Detection of mecR1 and mecI
The 414 bp PCR product of mecR1 was found in all 21 mecA-positive S. aureus, but did not occur in the absence of mecA. The 265 bp product of mecI was also detected in ten (48%) of the mecA-positive S. aureus. There was no correlation between methicillin MIC and the presence of mecI (Table II) .
mecR1 was detected in 42 of 44 mecA-positive CNS; it was not found in two mecA-positive S. haemolyticus. mecI was detected in 22 (50%) of the mecA-positive CNS.
There was no correlation between the methicillin MIC and the regulatory genes detected in each isolate (Table III) .
Pulsed-field gel electrophoresis
Analysis of the mecA-positive S. aureus by PFGE revealed 15 different patterns among the 21 isolates examined (Table II) . Four isolates gave pattern A, while patterns B, C and D were represented by two isolates each. All other S. aureus isolates had unique patterns.
Four groups of indistinguishable mecA-positive CNS were found after analysis by PFGE (Table III) . Patterns E and F were each represented by three isolates of S. epidermidis and pattern G by two isolates. Five S. simulans were included in pattern H. The other 14 S. epidermidis, six S. simulans, eight S. haemolyticus, two S. warneri and one S. hominis examined all produced distinct PFGE patterns.
Sequence of mecI and the mec promoter region
The sequence of the mecI gene was identical to the reference sequence in the four MRSA with PFGE pattern A (Table II) . The other six isolates of S. aureus had a 6 A G indicates an adenine to guanidine substitution in the mec promoter region. nd (not done) indicates that no sequence analysis was performed.
cytosine to thymine substitution at nucleotide 202 that produced a new termination codon. In all ten mecIpositive MRSA, the sequence of the mec promoter region was identical to the reference sequence.
The sequence of mecI was the same as that of the reference strain in all the CNS isolates tested (Table III) . Seven of the 15 isolates, all of them S. simulans, had a nucleotide substitution, adenine to guanine, in the mec promoter region (Figure) .
Discussion
Although mecA is present in all MRSA, there is considerable variation in the presence of the other genes involved in the expression of methicillin resistance. Previous studies have detected mecR1-mecI in 60-95% of mecA-positive S. aureus. 8, 20 It has been concluded that phenotypically resistant mecA-positive S. aureus either do not possess mecI or have mutations in the gene to prevent its function. 8, 10 When this is not the case, mutations in the MecI peptide binding site, the presumptive operator of mecA, have been located to explain the lack of mecI repression. 9 The few mecA-positive isolates which do not have these mutations are pre-MRSA, susceptible to methicillin in routine tests. 9 Eleven (52%) of the mecA-positive S. aureus examined in this study did not possess the mecI gene. These isolates were, therefore, able to express methicillin-resistance in the absence of its repressor effect. Six of the S. aureus carrying the gene were found to have a substitution in mecI at nucleotide 202, resulting in an in-frame stop codon in the middle of the open reading frame. This has been noted previously amongst British and European MRSA. [8] [9] [10] In these too, the repressor protein would not be produced, thus allowing full expression of methicillin resistance.
The four remaining mecA-positive S. aureus were indistinguishable by PFGE, all being of pattern A, and were therefore presumed to be the same strain. All were, unexpectedly, found to contain an intact mecI gene and had no mutation within the mec promoter region. This feature should result in a susceptible phenotype. Although the methicillin MICs for these organisms were indeed lower than those for the other MRSA sequenced, none of them were below the breakpoint (Table II) . It has previously been assumed that a mecI gene with the same sequence as the functioning gene in pre-MRSA N315 and with the same upstream regulatory sequence is capable of producing the MecI peptide, [8] [9] [10] although no assay has yet been developed to test this. These results suggest the presence of genetic changes in this strain, not detected in this study or in previous work, which prevent the transcription of mecI or the function of the MecI peptide.
Previous studies have detected mecI in six species of mecA-positive CNS. 8, 20 The gene sequence has, however, only been determined in 11 S. epidermidis. 10 Despite full expression of methicillin resistance, none of these isolates had a mutation within mecI. Examination of the mecI sequence in phenotypically resistant S. epidermidis, S. simulans and S. hominis in this study confirmed this finding as all had a nucleotide sequence corresponding to the functional gene found in the pre-MRSA N315. 6 There is, therefore, no evidence discovered so far to suggest that mutations in mecI play a role in the derepression of mecA in any CNS.
Changes in the presumptive operator for mecA, within the mec promoter region, have been found in MRSA, 9 but no mutations were located in the S. epidermidis strains examined. 10 In eight of the mecI-positive MRCNS studied here the mec promoter region sequence was the same as that in strain N315. 6 It is likely that, as above, there is another mechanism to account for the expression of methicillin resistance in the presence of a functional repression gene in many CNS species.
In this study, a mutation in the mec promoter region was found in every S. simulans sequenced and was not present in any other species examined. The origin of this change is unknown, although several possibilities exist. All these organisms were isolated from the same geographical area and may, therefore, have common ancestry. If this is the case, a mutation at some time in the past has been passed on to subsequent generations of S. simulans. Analysis by PFGE showed that there was one group of five indistinguishable isolates (pattern H). Other organisms in the same species produced patterns that were clearly distinct, which implies that there was not a recent common ancestor. It is also conceivable that this is the normal sequence for the mec promoter region in S. simulans. If so, function of the region may be normal and the nucleotide substitution may have no effect on the expression of methicillin resistance. The possibility is, therefore, raised that the mec region introduced into this species is different from that in other staphylococci, although this is not compatible with current theories of its molecular evolution. 9, 21 Until sequence data from S. simulans isolated from other areas are available these questions cannot be answered.
The mutation in S. simulans consisted of a nucleotide substitution in the mecR1 -35 promoter sequence (Figure) . As mecR1 and mecI form an operon, transcribed from the same start point, the function of both genes may be affected. This mutation is also within the presumptive operator for mecA, the binding site for the MecI peptide. Thus, even if mecI is transcribed, there may be no binding site for the gene product, which will, therefore, be unable to repress mecA.
When mecI is absent, there are also commonly deletions in the penicillin-binding domain at the 3 end of mecR1. 8 The primers used in this study amplified a single section of mecR1, within the predicted membrane-spanning domain, 22 500-900 bp from the 5 end. The presence of the whole gene can, therefore, only be predicted in those isolates found also to carry mecI. When mecR1 was detected in the absence of mecI, it is not known whether the penicillin-binding domain at the 3 end was present. In view of previous findings 8 it is likely that most, if not all, of the mecI-negative staphylococci examined have a significant part of mecR1 deleted.
No mecR1 product was detected in two mecA-positive S. haemolyticus in this study. As no separate investigation was made of the 5 terminus, outside the area covered by the primers, it is not known how much, if any, of this gene was present. Suzuki et al. 8 have previously described three mecA-positive S. haemolyticus without either the penicillin-binding or the membrane-spanning domains of mecR1. They performed further work that detected the terminal 53 bp at the 5 end, adjacent to mecA, indicating that mecR1 may once have been present. It is possible, therefore, that the isolates studied here have the same genetic organization as the formerly examined S. haemolyticus. 8 This particular configuration had not been found in S. aureus or any other species of CNS, leading to speculation that the mec region 5 to mecA is always different in S. haemolyticus. 21 However, six isolates of S. haemolyticus in this study were found to carry mecR1. Clearly mecR1 is not universally deleted in S. haemolyticus. Neither is the configuration in which the vast majority of the gene is missing confined to this species, as Kobayashi et al. 20 have found it in MRSA and methicillin-resistant S. epidermidis.
In summary, examination of this collection has revealed four S. aureus isolates from the same strain, seven S. epidermidis all with different PFGE patterns, and one S. hominis with full expression of methicillin resistance despite the presence of an intact mecI gene and mec promoter region. Phenotypic resistance in these isolates is, therefore, unexplained. The failure of mecI repression must, therefore, result from changes outside the areas examined. As mecI is part of an operon, its expression could be affected by alterations in genes or control regions upstream. Evidence was also found that mecR1 may be deleted more often in S. haemolyticus than in other staphylococcal species. The sequence of the mec promoter region of S. simulans was also consistently different. Further studies on mecA regulation in all staphylococcal species are needed. This may well shed light on some the complexities and ambiguities of expression of methicillin resistance observed here. Certainly it is not simply a product of interaction between the mecA, mecR1 and mecI genes. Some strains, and possibly whole species, seem to have acquired other mechanisms to evade repression of mecA.
